| Literature DB >> 32411153 |
Zhicai Wang1,2, Meili Zhao1, Hongqiu Cui1, Jian Li1, Meina Wang1,3.
Abstract
Many plants of Dendrobium genus are precious traditional herbs with high commercial value and excellent medicinal effects. They are perennial aerophytes or epiphytes of terrestrial orchids growing on cliffs and tree trunks covered with mosses in forests throughout the tropical and subtropical Asia and eastern Australia. The stem contains a variety of bioactive components, including polysaccharides and alkaloids, with strong antioxidant, neuroprotective, and immunomodulatory effects. Great attention has been drawn to the Dendrobium genus regarding its medicinal effectiveness, and the related researches have been accumulating rapidly in recent years. The bioactive components are mainly the intermediates or final products produced in specialized metabolite biosynthesis. Thus far, the activity, molecular structure, and composition of major medicinal ingredients have been partially elucidated, and the sequencing of several transcriptomes has been starting to shed new light on the biosynthesis regulation mechanism. This paper reviewed the advances of researches concerning the biosynthetic pathways of medicinal specialized metabolites from Dendrobium, especially the large number of related genes, with the hope of further promoting the development and utilization of those components and correspondingly protecting the Dendrobium resources in more effective ways.Entities:
Keywords: Dendrobium; biosynthesis; medicinal components; specialized metabolites; transcriptome
Year: 2020 PMID: 32411153 PMCID: PMC7198824 DOI: 10.3389/fpls.2020.00391
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
The effective components and their bioactivities in medicinal Dendrobium.
| Bioactive constituents | Species names | Bioactivity | References |
| Alkaloids | Neuroprotective activity | ||
| Bisbenzyls | Antifungal activities | ||
| Dendroflorin | Antisenescence | ||
| Flavonoids | Antioxidant, antitoxicity | ||
| Glucosyloxycinnamic acid derivatives | Antioxidant | ||
| Lectin | Hemagglutinating, antifungal | ||
| Moscatilin | Suppresses tumor angiogenesis and growth | ||
| Polysaccharides | Immunomodulatory, hepatoprotective, and antioxidant activities | ||
| Phenanthrenes | Antioxidant | ||
| Trigonopol A | Inhibits platelet aggregation |
Transcriptome sequencing of medicinal Dendrobium revealing genes related to specialized metabolites production.
| Sequencing time | Sequencing country | Sequencing platforms | References | |
| 2013 | China | Roche 454 GS FLX Titanium platform | ||
| 2015 | China | Illumina HiSeq 2000 | ||
| 2016 | China | Illumina HiSeq 2000 | ||
| 2016 | China | Illumina HiSeq 2000 | ||
| 2017 | China | Illumina HiSeq 2500 | ||
| 2017 | China | Illumina HiSeq 4000 | ||
| 2017 | China | Illumina HiSeq 1500 | ||
| 2018 | China | Illumina HiSeq 2500 | ||
| 2018 | China | Illumina HiSeq 4000 | ||
| 2019 | China | Illumina HiSeq 4000 | ||
| 2020 | China | Not available |
FIGURE 1Timeline of transcriptome studies probing the biosynthesis pathways for active ingredients in medicinal Dendrobium. Notable studies were included and the key references for each study were given.
FIGURE 2Putative biosynthetic pathways of polysaccharide and alkaloid in Dendrobium. In the polysaccharide biosynthesis pathway, monosaccharides (mannose, glucose, galactose, arabinose, xylose, etc.) are produced through hydrolysis or hydrolysis-derivative reactions. These monosaccharides as basic building blocks and repeating units are then used to synthesize polysaccharides. In the alkaloid biosynthesis pathway, the upstream precursors are produced mainly through the Shikimate pathway, and MVA and MEP pathways. Genes in red cells indicate the cloned and functionally studied genes in Dendrobium. The dashed lines indicate multiple steps. Enzyme abbreviations are as follows: PGM, phosphoglucomutase; UGP, UDP-glucose pyrophosphorylase; SPS, sucrose-phosphate synthase; Susy, sucrose synthase; DHS, 3-dexoy-7-phosphoheptulonate synthase; DHQS, 3-dehydroquinate synthase; DHD, 3-dehydroquinate dehydratase; SKDH, shikimate dehydrogenase; SK, shikimate kinase; SHKG, 3-phosphoshikimate 1-carboxyvinyltransferase; CS, chorismate synthase; HMGS, hydroxymethylglutaryl-CoA synthase; HMGR, 3-hydroxy-3-methylglutaryl CoA reductase; MVK, mevalonate kinase; PMK, phosphomevalonate kinase; MVD, diphosphomevalonate decarboxylase; DXS, 1-deoxy-D-xylulose-5-phosphate synthase; DXR, 1-deoxy-D-xylulose-5-phosphate reductoisomerase; CMS, 2-C-methyl-D-erythritol 4-phosphate cytidylyl transferase; CMK, 4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol kinase; MCS, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase; STR, strictosidine synthase.
FIGURE 3Biosynthesis of dendrobine in Dendrobium through the MEP pathway. The putative pathway was adapted from Li Q. et al. (2017) and Zheng et al. (2018). The enzymes or enzyme encoding genes were indicated alongside the arrows. The dashed lines indicate multiple steps.
Transcription factor families identified in the medicinal Dendrobium transcriptome datasets.
| No. of unique transcripts | ||||
| bHLH | 72 | 75 | 145 | 93 |
| bZIP | 49 | 23 | 227 | 23 |
| WRKY | 44 | 60 | 71 | 71 |
| MYB | 36 | 82 | 64 | 95 |
| NAC | 36 | 24 | 69 | 61 |
| GRAS | 24 | 4 | 37 | 15 |
| MADS | 13 | 30 | 28 | 25 |
| TCP | 13 | 6 | 24 | 25 |
FIGURE 4Integrated approaches for production of bioactive medicinal ingredients. Combining multiple “omics” datasets will facilitate the discovery of novel bioactive specialized metabolites and characterization of the related biosynthesis pathways in Dendrobium species. Based on the obtained knowledge, novel combinatorial biosynthesis systems can be engineered for the production of new and interesting specialized metabolites.